BWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production Elizabeth Masencup July 22, 2024
BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration Elizabeth Masencup June 7, 2024
BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology Elizabeth Masencup November 16, 2023
BWXT Medical Submits Tc-99m Generator New Drug Application to FDA Elizabeth Masencup September 13, 2022
BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products Elizabeth Masencup June 27, 2022
BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products Elizabeth Masencup June 13, 2022
BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225 Matt Stefanich September 16, 2021
BWXT and GMS Form Joint Venture in Nuclear Medicine Manufacturing and Distribution in the Asia-Pacific Region Matt Stefanich March 8, 2021
